IBDEI35V ; ; 04-FEB-2020
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,50475,1,3,0)
;;=3^Sexual Dysfnct Not d/t Substance/Known Physiological Cond
;;^UTILITY(U,$J,358.3,50475,1,4,0)
;;=4^F52.8
;;^UTILITY(U,$J,358.3,50475,2)
;;=^5003624
;;^UTILITY(U,$J,358.3,50476,0)
;;=F52.21^^193^2494^33
;;^UTILITY(U,$J,358.3,50476,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50476,1,3,0)
;;=3^Erectile Disorder,Male (Psychogenic)
;;^UTILITY(U,$J,358.3,50476,1,4,0)
;;=4^F52.21
;;^UTILITY(U,$J,358.3,50476,2)
;;=^5003620
;;^UTILITY(U,$J,358.3,50477,0)
;;=I12.9^^193^2494^59
;;^UTILITY(U,$J,358.3,50477,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50477,1,3,0)
;;=3^Hypertensive Kidney Disease Chronic w/ Stg 1-4
;;^UTILITY(U,$J,358.3,50477,1,4,0)
;;=4^I12.9
;;^UTILITY(U,$J,358.3,50477,2)
;;=^5007066
;;^UTILITY(U,$J,358.3,50478,0)
;;=N04.9^^193^2494^76
;;^UTILITY(U,$J,358.3,50478,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50478,1,3,0)
;;=3^Nephrotic Syndrome w/ Unspec Morphologic Changes
;;^UTILITY(U,$J,358.3,50478,1,4,0)
;;=4^N04.9
;;^UTILITY(U,$J,358.3,50478,2)
;;=^5015540
;;^UTILITY(U,$J,358.3,50479,0)
;;=N02.9^^193^2494^53
;;^UTILITY(U,$J,358.3,50479,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50479,1,3,0)
;;=3^Hematuria w/ Unspec Morphologic Changes,Recurrent & Persistent
;;^UTILITY(U,$J,358.3,50479,1,4,0)
;;=4^N02.9
;;^UTILITY(U,$J,358.3,50479,2)
;;=^5015520
;;^UTILITY(U,$J,358.3,50480,0)
;;=N06.9^^193^2494^93
;;^UTILITY(U,$J,358.3,50480,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50480,1,3,0)
;;=3^Proteinuria Isolated w/ Unspec Morphologic Lesion
;;^UTILITY(U,$J,358.3,50480,1,4,0)
;;=4^N06.9
;;^UTILITY(U,$J,358.3,50480,2)
;;=^5015558
;;^UTILITY(U,$J,358.3,50481,0)
;;=N05.9^^193^2494^73
;;^UTILITY(U,$J,358.3,50481,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50481,1,3,0)
;;=3^Nephritic Syndrome w/ Unspec Morphologic Changes
;;^UTILITY(U,$J,358.3,50481,1,4,0)
;;=4^N05.9
;;^UTILITY(U,$J,358.3,50481,2)
;;=^5134086
;;^UTILITY(U,$J,358.3,50482,0)
;;=N07.9^^193^2494^75
;;^UTILITY(U,$J,358.3,50482,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50482,1,3,0)
;;=3^Nephropathy Hereditary w/ Unspec Morphologic Lesions
;;^UTILITY(U,$J,358.3,50482,1,4,0)
;;=4^N07.9
;;^UTILITY(U,$J,358.3,50482,2)
;;=^5015568
;;^UTILITY(U,$J,358.3,50483,0)
;;=N15.9^^193^2494^100
;;^UTILITY(U,$J,358.3,50483,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50483,1,3,0)
;;=3^Renal Tubulo-Interstitial Disease,Unspec
;;^UTILITY(U,$J,358.3,50483,1,4,0)
;;=4^N15.9
;;^UTILITY(U,$J,358.3,50483,2)
;;=^5015596
;;^UTILITY(U,$J,358.3,50484,0)
;;=N17.9^^193^2494^65
;;^UTILITY(U,$J,358.3,50484,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50484,1,3,0)
;;=3^Kidney Failure,Acute,Unspec
;;^UTILITY(U,$J,358.3,50484,1,4,0)
;;=4^N17.9
;;^UTILITY(U,$J,358.3,50484,2)
;;=^338532
;;^UTILITY(U,$J,358.3,50485,0)
;;=N19.^^193^2494^66
;;^UTILITY(U,$J,358.3,50485,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50485,1,3,0)
;;=3^Kidney Failure,Unspec
;;^UTILITY(U,$J,358.3,50485,1,4,0)
;;=4^N19.
;;^UTILITY(U,$J,358.3,50485,2)
;;=^5015607
;;^UTILITY(U,$J,358.3,50486,0)
;;=N11.0^^193^2494^97
;;^UTILITY(U,$J,358.3,50486,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50486,1,3,0)
;;=3^Pyelonephritis,Chronic Nonobstructive Reflux-Associated
;;^UTILITY(U,$J,358.3,50486,1,4,0)
;;=4^N11.0
;;^UTILITY(U,$J,358.3,50486,2)
;;=^5015571
;;^UTILITY(U,$J,358.3,50487,0)
;;=N10.^^193^2494^74
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI35V 3778 printed Dec 13, 2024@02:42:24 Page 2
IBDEI35V ; ; 04-FEB-2020
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,50475,1,3,0)
+2 ;;=3^Sexual Dysfnct Not d/t Substance/Known Physiological Cond
+3 ;;^UTILITY(U,$J,358.3,50475,1,4,0)
+4 ;;=4^F52.8
+5 ;;^UTILITY(U,$J,358.3,50475,2)
+6 ;;=^5003624
+7 ;;^UTILITY(U,$J,358.3,50476,0)
+8 ;;=F52.21^^193^2494^33
+9 ;;^UTILITY(U,$J,358.3,50476,1,0)
+10 ;;=^358.31IA^4^2
+11 ;;^UTILITY(U,$J,358.3,50476,1,3,0)
+12 ;;=3^Erectile Disorder,Male (Psychogenic)
+13 ;;^UTILITY(U,$J,358.3,50476,1,4,0)
+14 ;;=4^F52.21
+15 ;;^UTILITY(U,$J,358.3,50476,2)
+16 ;;=^5003620
+17 ;;^UTILITY(U,$J,358.3,50477,0)
+18 ;;=I12.9^^193^2494^59
+19 ;;^UTILITY(U,$J,358.3,50477,1,0)
+20 ;;=^358.31IA^4^2
+21 ;;^UTILITY(U,$J,358.3,50477,1,3,0)
+22 ;;=3^Hypertensive Kidney Disease Chronic w/ Stg 1-4
+23 ;;^UTILITY(U,$J,358.3,50477,1,4,0)
+24 ;;=4^I12.9
+25 ;;^UTILITY(U,$J,358.3,50477,2)
+26 ;;=^5007066
+27 ;;^UTILITY(U,$J,358.3,50478,0)
+28 ;;=N04.9^^193^2494^76
+29 ;;^UTILITY(U,$J,358.3,50478,1,0)
+30 ;;=^358.31IA^4^2
+31 ;;^UTILITY(U,$J,358.3,50478,1,3,0)
+32 ;;=3^Nephrotic Syndrome w/ Unspec Morphologic Changes
+33 ;;^UTILITY(U,$J,358.3,50478,1,4,0)
+34 ;;=4^N04.9
+35 ;;^UTILITY(U,$J,358.3,50478,2)
+36 ;;=^5015540
+37 ;;^UTILITY(U,$J,358.3,50479,0)
+38 ;;=N02.9^^193^2494^53
+39 ;;^UTILITY(U,$J,358.3,50479,1,0)
+40 ;;=^358.31IA^4^2
+41 ;;^UTILITY(U,$J,358.3,50479,1,3,0)
+42 ;;=3^Hematuria w/ Unspec Morphologic Changes,Recurrent & Persistent
+43 ;;^UTILITY(U,$J,358.3,50479,1,4,0)
+44 ;;=4^N02.9
+45 ;;^UTILITY(U,$J,358.3,50479,2)
+46 ;;=^5015520
+47 ;;^UTILITY(U,$J,358.3,50480,0)
+48 ;;=N06.9^^193^2494^93
+49 ;;^UTILITY(U,$J,358.3,50480,1,0)
+50 ;;=^358.31IA^4^2
+51 ;;^UTILITY(U,$J,358.3,50480,1,3,0)
+52 ;;=3^Proteinuria Isolated w/ Unspec Morphologic Lesion
+53 ;;^UTILITY(U,$J,358.3,50480,1,4,0)
+54 ;;=4^N06.9
+55 ;;^UTILITY(U,$J,358.3,50480,2)
+56 ;;=^5015558
+57 ;;^UTILITY(U,$J,358.3,50481,0)
+58 ;;=N05.9^^193^2494^73
+59 ;;^UTILITY(U,$J,358.3,50481,1,0)
+60 ;;=^358.31IA^4^2
+61 ;;^UTILITY(U,$J,358.3,50481,1,3,0)
+62 ;;=3^Nephritic Syndrome w/ Unspec Morphologic Changes
+63 ;;^UTILITY(U,$J,358.3,50481,1,4,0)
+64 ;;=4^N05.9
+65 ;;^UTILITY(U,$J,358.3,50481,2)
+66 ;;=^5134086
+67 ;;^UTILITY(U,$J,358.3,50482,0)
+68 ;;=N07.9^^193^2494^75
+69 ;;^UTILITY(U,$J,358.3,50482,1,0)
+70 ;;=^358.31IA^4^2
+71 ;;^UTILITY(U,$J,358.3,50482,1,3,0)
+72 ;;=3^Nephropathy Hereditary w/ Unspec Morphologic Lesions
+73 ;;^UTILITY(U,$J,358.3,50482,1,4,0)
+74 ;;=4^N07.9
+75 ;;^UTILITY(U,$J,358.3,50482,2)
+76 ;;=^5015568
+77 ;;^UTILITY(U,$J,358.3,50483,0)
+78 ;;=N15.9^^193^2494^100
+79 ;;^UTILITY(U,$J,358.3,50483,1,0)
+80 ;;=^358.31IA^4^2
+81 ;;^UTILITY(U,$J,358.3,50483,1,3,0)
+82 ;;=3^Renal Tubulo-Interstitial Disease,Unspec
+83 ;;^UTILITY(U,$J,358.3,50483,1,4,0)
+84 ;;=4^N15.9
+85 ;;^UTILITY(U,$J,358.3,50483,2)
+86 ;;=^5015596
+87 ;;^UTILITY(U,$J,358.3,50484,0)
+88 ;;=N17.9^^193^2494^65
+89 ;;^UTILITY(U,$J,358.3,50484,1,0)
+90 ;;=^358.31IA^4^2
+91 ;;^UTILITY(U,$J,358.3,50484,1,3,0)
+92 ;;=3^Kidney Failure,Acute,Unspec
+93 ;;^UTILITY(U,$J,358.3,50484,1,4,0)
+94 ;;=4^N17.9
+95 ;;^UTILITY(U,$J,358.3,50484,2)
+96 ;;=^338532
+97 ;;^UTILITY(U,$J,358.3,50485,0)
+98 ;;=N19.^^193^2494^66
+99 ;;^UTILITY(U,$J,358.3,50485,1,0)
+100 ;;=^358.31IA^4^2
+101 ;;^UTILITY(U,$J,358.3,50485,1,3,0)
+102 ;;=3^Kidney Failure,Unspec
+103 ;;^UTILITY(U,$J,358.3,50485,1,4,0)
+104 ;;=4^N19.
+105 ;;^UTILITY(U,$J,358.3,50485,2)
+106 ;;=^5015607
+107 ;;^UTILITY(U,$J,358.3,50486,0)
+108 ;;=N11.0^^193^2494^97
+109 ;;^UTILITY(U,$J,358.3,50486,1,0)
+110 ;;=^358.31IA^4^2
+111 ;;^UTILITY(U,$J,358.3,50486,1,3,0)
+112 ;;=3^Pyelonephritis,Chronic Nonobstructive Reflux-Associated
+113 ;;^UTILITY(U,$J,358.3,50486,1,4,0)
+114 ;;=4^N11.0
+115 ;;^UTILITY(U,$J,358.3,50486,2)
+116 ;;=^5015571
+117 ;;^UTILITY(U,$J,358.3,50487,0)
+118 ;;=N10.^^193^2494^74
